mifegyne tableta - תוצאות חיפוש

צייטוטק 200 מקג טבליות

pfizer pfe pharmaceuticals israel ltd - misoprostol - טבליה - misoprostol 200 mcg - misoprostol - misoprostol - for the treatment of duodenal and gastric ulcer.treatment and prevention nsaid induced ulcers lesions, erosions, while nsaid therapy continues.use in conjunction with mifepristone subject to the approval of a committee for the termination of pregnancy according to the israeli penal law 1977.first-trimester pregnancy failure: use is intended for emptying the uterus in states of first trimester pregnancy failure, including: presentation of a pregnancy sac in the uterus with no fetal echo, missed abortion (until week 11+6 and a fetus 40 mm in length) or incomplete abortion. the preparation is to be used after location of the sac in the uterus has been proved and the diagnosis of pregnancy failure is certain. the preparation can be used for this purpose in an ambulatory setting. the dosage and route of administration will be similar to the use of cytotec in pregnancy termination after using mifegyne. informed consent and medical surveillance are required.softening and dilation of the cervix for performing intraut

ישראל - עברית - Ministry of Health

מיפג'ין

a. lapidot pharmaceuticals, ltd - mifepristone - טבליה - mifepristone 200 mg - mifepristone - mifepristone - medical alternative to uterine suction for termination of intra-utrerine pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after mifegyne intake. under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

ישראל - עברית - Ministry of Health

ויזודיין

novartis pharma services ag - verteporfin 15 mg/vial - solution for infusion - verteporfin - visudyne is indicated for the treatment of patients with predominantly classic or occult subfoveal choroidal neovascularization due to age related macular degeneration, or with subfoveal choroidal neovascularization caused by other macular diseases.

ישראל - עברית - Ministry of Health

medical devices for gynecological use, according to the below list

קיור מדיקל אנד טכניקל סופלאי - רופא - אביזרים לשימוש גניקולוגי

ישראל - עברית - Ministry of Health

"electrodes, diathermic blades,plates "

"דובר מכשור רפואי ומדעי בע""מ" - רופא - דיאטרמיה

ישראל - עברית - Ministry of Health

accessories for operating rooms

אורטה מדיקל בע"מ - רופא - מיועד לבתי חולים,מרפאות עם חדרי ניתוח

ישראל - עברית - Ministry of Health

accessories for operating rooms

אורטה מדיקל בע"מ - רופא - מיועד לבתי חולים,מרפאות עם חדרי ניתוח